We are very pleased to announce the Sixth International Fluid Academy Days, which will take place on November 23-25th 2017 at the Hilton Hotel in Antwerp, Belgium.
The aim of this sixth edition is again to review recent advances in fluid management, and hemodynamic and organ function monitoring in the critical care setting in a comprehensive manner for intensivists, anaesthesiologists and emergency physicians as well as interested internists and surgeons. However the meeting will deal with any broad topic related to critical care. As always it is also a great way to promote professional interaction between faculty members, participants and delegates of the industry.
This website does not accept nor host any advertisement.
Download the information brochure here
A passion for medical technology and ensuring the availability of optimal total solutions in all circumstances. Acertys, as a partner for hospitals and medical professionals, only wants what is best for both staff and patients.
Our products comprise the medication needed to relieve symptoms and significantly improve the quality of life, as well as medication that is primarily used in critical, life-threatening situations. That is why we maintain constant communication with medical specialists and focus on the real needs in medical practice to develop products in line with actual clinical requirements.
Highest quality standards, delivery reliability and a strong drive to excel as a team are fundamentally important to us. We act swiftly and flexibly to find the right solutions – in close consultation with medical specialists and for the benefit of patients. We share the responsibility for the smooth functioning of medical measures at the decisive moment. Whether owner or team members - at AMOMED Pharma, we are fully aware of the importance of our actions and are deeply committed to the far-reaching aspect of our work.
B. Braun supports the International Fluid Academy first of all because of their mutual interest in fluid management. Therefore you can find us at our booth during the 6th International Fluid Academy Days November 2017 in Antwerp. Our B. Braun colleagues are more than willing to share expertise about the recent developments in fluid management!
Who is B. Braun? B. Braun is one of the world's leading providers of healthcare products today. We supply the global healthcare market with products and systems for anesthesia, intensive care, cardiology, extracorporeal blood treatment and surgery. We also provide services for clinics, physicians in private practices and the home care sector.
Baxter develops, manufactures and markets products and therapies that save and sustain the lives of people with hemophilia, immune disorders, cancers, kidney disease, malnutrition and other acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in pharmaceuticals, biotechnology and medical devices to create products that advance patient care worldwide.
Braedius Medical is a global medical technology company that was founded in 2010 to develop and commercialise state of the art bedside imaging technology
The Braedius CytoCam offers a complete solution for microcirculation assessment.
The Braedius CytoCam has obtained CE registration and FDA clearance.
CytoCam is currently being used in hospitals in the US, UK, Netherlands, Belgium, France, Germany, Australia, Italy, Switzerland and Lithuania and new installations are constantly underway.
CytoCam is available for sale worldwide.
CAF-DCF is een Belgische vennootschap, die zich gespecialiseerd heeft in de productie van stabiele plasmaderivaten: stollingsfactoren, immunoglobulinen en albumine oplossingen. Voor de bereiding van deze plasmaderivaten voor de Belgische gezondheidszorg, wordt plasma gebruikt, afgenomen bij vrijwillige en onbetaalde donoren. De inzet van dit bloedplasma afgestaan door de donor en de aanmaak van producten voor patiënten vormen de hoeksteen van een "human to human approach".
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas - Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices - ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit: www.convatec.com.
A global pioneer in medical breakthroughs, Cook Medical is committed to creating effective solutions that benefit millions of patients worldwide. Today, we combine medical devices, drugs, biologic grafts and cell therapies across more than 16,000 products serving more than 40 medical specialties. Founded in 1963 by a visionary who put patient needs and ethical business practices first, Cook is a family-owned company that has created more than 10,000 jobs worldwide. For more information, visit our website.
CytoSorbents Corporation is a critical care focused immunotherapy company using blood purification to modulate systemic inflammation - with the goal of preventing or treating multi-organ failure in life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and adsorption.
Turn your data into an interactive data story report
DataStories International NV is an award-winning advanced predictive analytics company based in Turnhout, Belgium. Our AI-based automated analytics platform automatically analyzes relationships in spreadsheet data, builds forecasts and creates interactive what-of scenarios. With DataStories you can take data from various sources such as risk and safety, medical treatment statistics, experimental R&D, life sciences or sales, and distill the minimum number of variables needed to optimally your predict target variables and KPIs. The results are presented in an interactive narrative, a story about your data.
Dirinco is een patiëntgedreven organisatie volgens het principe dat kwaliteit van leven bovenaan staat. Wij streven hiernaar door inzet van onze hoogkwalitatieve producten, procedures en medewerkers.
Door onze meer dan 30 jaar toegewijde ervaring in de markt van chronisch en acuut nierfalen leveren we elke dag een prestatie om patiënt en eindgebruiker het optimale klinische resultaat te bieden.
De patiënt als mens staat centraal!
"We do everything we do with passion - and we do it for life." (Stefan Drager, Executive Board Chairman)
As an international leader in medical and safety technology, Drager develops innovative equipment and solutions that people all over the world over trust when lives are on the line. Our medical division's product range covers anesthesia workstations, ventilation equipment for intensive care, emergency, neonatal and mobile ventilation units, warming therapy equipment for infants, patient monitoring equipment, IT solutions, architectural systems and gas management systems.
Edwards Lifesciences has been advancing the care of the acutely ill for over 40 years. We are focused on helping clinicians enhance knowledge and standardize practice to improve the quality and efficiency of care. Edwards is dedicated to providing evidence-based medicine programs such as the Enhanced Surgical Recovery Program that facilitates the implementation and compliance of protocolized care in the OR in order to reduce post-surgical complications. Edwards also offers a range of advanced monitoring tools – including noninvasive to minimally-invasive hemodynamic monitoring and continuous glucose monitoring – expansive educational resources, and clinical support to ensure sustained compliance.
Esaote is one of the world’s leading producers of medical diagnostic systems and internationally acknowledged to be the world leader in dedicated MRI. The Esaote Group is also one of the main players in the sector of Information Technology for healthcare.
Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market. All over the world more than 24,000 employees are committed to improving the quality of life of critically and chronically ill patients with innovative products for patients in hospitals and outpatients.
SonoSite, Inc. (www.sonosite.com ), a subsidiary of FUJIFILM, is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. Size is everything for SonoSite. The firm makes handheld ultrasonic imaging devices that health care providers can use outside traditional imaging facilities, for instance, in the ER, at a patient's bedside, or in the doctor's office. Its fourth- and fifth-generation systems include the handheld NanoMaxx tool and the M-Turbo and Edge portable consoles that produce imaging quality comparable to larger cart-based systems. Its S Series of products feature customized interfaces for different clinical applications, including the ER or the ICU.
The critical condition of the ICU patient requires sage, efficient and flexible therapeutic options. Gambro has used its know how in blood purification to develop innovative concepts to offer treatments for renal and liver failure.
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to morepeople around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world.
In the early 50's, Mr Henry Nootens was already active in the World of the hospitals. In 1957 he founded, together with his wife Mrs Gilberte Poels, the company named H. Nootens SA. Those days, the fundamentals of the gamma of hospitalization were made. The range of products contained needles and syringes, sterilization boxes, urologic catheters, endotracheal tubes, all kinds o bandages etc.
Their Son, Jean-Jacques Nootens, enters the family company in 1968 and he decides to create the surgical department. This department offers a range of products for the use in the OR: surgical instruments, instruments for thoracic drainage, orthopedic en ophthalmologic implants. Mr Andre Lombarts starts in 1978 as the head of the department of hospitalization and as the chief of finances. In 1995, Mrs Valerie-Anne Nootens starts in the company to improve the impact of marketing. In 1998 she becomes the head of quality care. Pierre-Henri Nootens joins the team in 2002 and he takes care of the stocks of our different suppliers.
These days, our team of 12 specialized representatives visits the hospitals on daily basis. The group Hospiplan-Nootens was erected in 1996 to adept the activities better to the reality of the European market. Nowadays, Hospiplan focuses on the commercialization of the new products which demand optimalization following the Belgian and Luxembourgian specificities.
Philosophy of the company
H Nootens SA became well known thanks to the good quality of service to the world of surgery and hospitals. Following our philosophy, we are convinced that it is important to listen very carefully to the needs of our clients to give a good service. Thanks to a good management of our stock, we are able to supply most of our orders of common products to the hospitals in a small amount of time. During 2004, efforts in the area of Quality Care made it possible to acquire the certificate ISO 9001-2000 and EN 13485:2003.
Maltron is a leading manufacturer of Bio-electrical and Electrical Impedance Tomography used in the assessments of Body and Abdominal Composition, Malnutrition, Fluid Monitoring and for monitoring lung diseases bedside by leading hospitals and institute worldwide. The company focus is on the research, development, manufacture and marketing of innovative products. Maltron products are well known for quality, reliability and consistent reproducibility providing reliable assessment of Body Composition and hydration in a simple, safe and scientific manner.
Maquet, a trusted partner for hospitals and physicians for more than 175 years, is a global leader in medical systems. The company offers innovative therapy solutions and infraY structure capabilities for highYacuity areas within the hospital Y including the operating room, hybrid OR, and intensive care unit Y as well as intraY and interYhospital patient transport. Additionally, Maquet develops intelligent and sustainable room concepts that exceed the expectations of modern hospitals, working in close cooperation with customers, production engineers and architects to integrate high quality products and services. Headquartered in Rastatt, Germany, Maquet is the largest subsidiary of the publicly listed Getinge Group AB of Sweden. Maquet generated about 1.55 billion Euros in 2014, representing more than half of the Getinge Group’s annual revenue of 2.93 billion Euros. Maquet has around 7,000 employees and provides 53 international sales and service organizations. Maquet is The Gold Standard. For more information, please visit www.maquet.com.
Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET® pulse oximetry, Masimo Rainbow Pulse CO-Oximetry and new Masimo noninvasive and continuous total hemoglobin (SpHb™) monitoring technology. The recent introduction of the first-and-only FDA-cleared technology that noninvasively and continuously measures total hemoglobin without a painful needle stick and invasive blood draw is expected to open new markets and significantly expand the company’s growth opportunities.
Bellco offers worldwide therapeutic systems for blood purification in Dialysis, Intensive Care, Cardiology. Since 1972, Bellco has continually been developing highly reliable, sophisticated products aimed at renal treatments. The current product range for advanced haemodiafiltration treatments shows that the company is steering towards becoming even more specialised in personalised products dedicated to specific renal conditions.
MTT is specialised in non-invasive monitoring of Ventilation and Perfusion. The Evidence Based Monitoring technology for Hemodynamic optimization of IC and OR patients, the Oesophagale Doppler Monitor ODM.
ODM-guided fluid management is a cornerstone of Enhanced Recovery, delivering better quality, more cost effective care as it means patients recover from their surgery faster and leave hospital sooner and in better health than they otherwise would do.
What NICE said about Cardio-Q Doppler
". . .The case for adopting the CardioQ-ODM in the NHS,. . .is supported by the evidence. . .The CardioQ ODM should be considered for use in patients undergoing major or high-risk surgery or other surgical patients in whom a clinician would consider using invasive cardiovascular monitoring. This will include patients undergoing major or high-risk surgery or high risk patients undergoing intermediate-risk surgery." NICE: Medical Technology guidance 3. National Institute for Health and Clinical Excellent, March 2011.
Medical Technology Transfer is founded in 1993 and has the ambition to effectively support medical practice and medical treatment with carefully selected, evidence based technologies.
MTT focuses on the introduction, delivery and maintenance of directly applicable clinical measuring, monitoring and respiratory equipment and related systems with high added value. Neonatology, developmental care and optimal care of the heart and lung function are focus points.
At the same time is an excellent support to both doctors and nurses as well as medical physicists and medical technicians a high priority. Hereto MTT offers training standard with procurement of a system and a telephone helpline 24 hours, seven days a week available for user questions and emergency support.
Also the short and long term rental of systems belongs to the possibilities. The "budget save rent" is developed together with some major clients and is frequently asked for nowadays.
MTT supports medical research and promotes the exchange of knowledge and experience between users and manufacturers.
Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests, a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler ® pulmonary drugs.
At Pfizer, we apply science and use our global resources to improve health and well-being at every stage of life. Consistent with our responsibility as the leading biopharmaceutical company, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care. Our 2000 colleagues in Belgium work in all stages of drug development. The production plant at Puurs and the Phase I Clinical Research Unit in Brussels are worldwide recognized for their expertise in innovation.
Philips Medical Systems consists of patient monitoring and clinical information systems, automated external defibrillators, such as HeartStrart, and electrocardiography. These products are targeted at health providers including hospitals, outpatient clinic, physician offices, emergency rooms, and home-health services.
Founded more than 20 years ago in Munich Germany, Pulsion has become a leading specialist in haemodynamic monitoring and provides the clinician with a variety of technologies to optimise the haemodynamic management of patients in ICU and in the OR; transpulmonary thermodilution technique for cardiac output, preload and lung water measurements (PiCCO); fibreoptic continuous measurement of the central venous oxygen saturation via standard CVC (CeVOX); non-invasive evaluation of the liver function and splanchnic perfusion with indocyanine green dye (LiMON); non-calibrated CO trend measurement via standard arterial line (ProAQT); and the PulsioFlex monitoring platform with the modular concept to enable patient centred flexibility.
XENIOS’ novalung iLA, i–cor, and medos devices
XENIOS is the therapy and technology leader in minimally invasive lung and heart assist. XENIOS’ novalung iLA, i–cor, and medos devices provide pulmonary and cardiac assist for a broad range of support levels on the unique XENIOS platform. XENIOS’ novalung iLA therapy is an adjunct or an alternative to injurious, immobilizing mechanical ventilation. XENIOS i-cor therapy is a novel less invasive heart assist therapy synchronized with the human heartbeat. These therapies enable caregivers to keep lung failure patients awake, self-determined and mobile while preventing ventilator-associated lung injury, pneumonia, and breathing muscle damage.